Showing results (891-900 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|April 27, 2023
Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant RegistryMikaël Chetboun, Elodie Drumez, Cassandra Ballou, et al.
The Lancet. Diabetes & Endocrinology|April 2, 2023
Vitamin D: 100 years of discoveries, yet controversy continuesJ Christopher Gallagher, Clifford J Rosen
The Lancet. Diabetes & Endocrinology|August 18, 2025
Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trialSoo Lim, Supawan Buranapin, Xiaolei Bao, et al.
The Lancet. Diabetes & Endocrinology|August 14, 2025
The central role of recovery of β-cell function in the remission of prediabetes: a prospective cohort study in CanadaRavi Retnakaran, Jiajie Pu, Junwei Shen, et al.
The Lancet. Diabetes & Endocrinology|November 13, 2025
Life stage transitions for people with type 1 diabetesRebecca J Vitale, Elena Toschi, Jacob Ortega, et al.
The Lancet. Diabetes & Endocrinology|October 30, 2025
Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trialLixin Guo, Xiaolin Dong, Jianhua Ma, et al.
The Lancet. Diabetes & Endocrinology|July 24, 2025
Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional studyJean Claude Katte, Steven Squires, Mesmin Y Dehayem, et al.
The Lancet. Diabetes & Endocrinology|July 12, 2025
Parental preconception BMI and risk of adverse birth outcomes in 8 million parent-child triads: a nationwide population-based cohort study in ChinaBuyun Liu, Chuanyu Zhao, Ying Yang, et al.
The Lancet. Diabetes & Endocrinology|July 10, 2025
Incretins and the cardiovascular system: bridging digestion with metabolismAngelo Avogaro, Gian Paolo Fadini
The Lancet. Diabetes & Endocrinology|September 17, 2025
Once-weekly semaglutide 7·2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trialIldiko Lingvay, Sara J Bergenheim, John B Buse, et al.
Pageof 93